Effect of cellular mass on chondrogenic differentiation during embryoid body formation

Lach,Michał   Stefan; Kulcenty,Katarzyna; Jankowska,Karolina; Trzeciak,Tomasz; Richter,Magdalena; Suchorska,Wiktoria   Maria

doi:10.3892/mmr.2018.9272

Effect of cellular mass on chondrogenic differentiation during embryoid body formation

Authors:
- Michał Stefan Lach
- Katarzyna Kulcenty
- Karolina Jankowska
- Tomasz Trzeciak
- Magdalena Richter
- Wiktoria Maria Suchorska
View Affiliations

Affiliations: Radiobiology Lab, Greater Poland Cancer Centre, 61‑866 Poznan, Poland, Department of Orthopaedics and Traumatology, Poznan University of Medical Sciences, 61‑545 Poznan, Poland
Published online on: July 10, 2018 https://doi.org/10.3892/mmr.2018.9272
Pages: 2705-2714
Copyright: © Lach et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

One approach to cell differentiation is to use the natural capacity of pluripotent stem cells to form three germ layers via embryoid bodies (EB). However, unification of this process during in vitro culture remains challenging and many microenvironmental factors including the number of cells in the culture can influence differentiation patterns. The number of cells serves a crucial role as it determines access to nutrients, the distribution of oxygen concentration and cellular interactions, all of which influence the fate of the differentiated cells. The influence of EBs derived from human pluripotent cells on the chondrogenic potential of such cells is not well understood. For this reason, the present study sought to determine the effect of varying amounts of cells on the properties of EBs derived from human embryonic stem cells (BG01V cell line). In the present study, 500‑2,000 cells per well were cultivated from 5 to 15 days in suspension cell culture. Expression of pluripotency genes and germ layer markers were evaluated in order to determine the EBs with the greatest and least mesodermal properties. Genes associated with pluripotency and chondrogenesis were also evaluated to assess the influence of suspension culture duration and EB size on chondrogenic differentiation. Immunofluorescence staining for pluripotent and chondrocyte‑associated proteins confirmed successful differentiation into chondrocyte‑like cells. Alcian blue staining confirmed deposition of proteoglycans. These results suggested that EBs formed in 500‑cell wells possess the highest mesodermal and prochondrogenic properties. Differentiation of EBs into chondrocytes on day 5 in 500‑cell wells was more efficient than in that observed in larger and older EBs.

View Figures

View References

1	de Windt TS, Vonk LA, Brittberg M and Saris DBF: Treatment and prevention of (Early) osteoarthritis using articular cartilage repair-fact or fiction? A systematic review. Cartilage. 4 3 Suppl:5S–12S. 2013. View Article : Google Scholar : PubMed/NCBI
2	Li Y, Wei X, Zhou J and Wei L: The age-related changes in cartilage and osteoarthritis. Biomed Res Int. 2013:9165302013.PubMed/NCBI
3	Madry H, Luyten FP and Facchini A: Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 20:407–422. 2012. View Article : Google Scholar : PubMed/NCBI
4	Teixeira Moreira LS, Leijten JC, Sobral J, Jin R, van Apeldoorn AA, Feijen J, van Blitterswijk C, Dijkstra PJ and Karperien M: High throughput generated micro-aggregates of chondrocytes stimulate cartilage formation in vitro and in vivo. Eur Cell Mater. 23:387–399. 2012. View Article : Google Scholar : PubMed/NCBI
5	Caron MM, Emans PJ, Coolsen MM, Voss L, Surtel DA, Cremers A, van Rhijn LW and Welting TJ: Redifferentiation of dedifferentiated human articular chondrocytes: Comparison of 2D and 3D cultures. Osteoarthritis Cartilage. 20:1170–1178. 2012. View Article : Google Scholar : PubMed/NCBI
6	Carroll SH and Ravid K: Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: A focus on adenosine receptors. Expert Rev Mol Med. 15:e12013. View Article : Google Scholar : PubMed/NCBI
7	Solchaga LA, Penick KJ and Welter JF: Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: Tips and tricksMethods in molecular biology. 698. Vemuri M, Chase LG and Rao MS: Humana Press; Totowa, NJ: pp. 253–278. 2011, View Article : Google Scholar : PubMed/NCBI
8	Kanawa M, Igarashi A, Ronald VS, Higashi Y, Kurihara H, Sugiyama M, Saskianti T, Pan H and Kato Y: Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2. Cytotherapy. 15:1062–1072. 2013. View Article : Google Scholar : PubMed/NCBI
9	Ko JY, Kim KI, Park S and Im GI: In vitro chondrogenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells. Biomaterials. 35:3571–3581. 2014. View Article : Google Scholar : PubMed/NCBI
10	Tsumaki N, Okada M and Yamashita A: iPS cell technologies and cartilage regeneration. Bone. 70:48–54. 2015. View Article : Google Scholar : PubMed/NCBI
11	Robinton DA and Daley GQ: The promise of induced pluripotent stem cells in research and therapy. Nature. 481:295–305. 2012. View Article : Google Scholar : PubMed/NCBI
12	Beers J, Linask KL, Chen JA, Siniscalchi LI, Lin Y, Zheng W, Rao M and Chen G: A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. Sci Rep. 5:113192015. View Article : Google Scholar : PubMed/NCBI
13	Toh WS, Guo XM, Choo AB, Lu K, Lee EH and Cao T: Differentiation and enrichment of expandable chondrogenic cells from human embryonic stem cells in vitro. J Cell Mol Med. 13:3570–3590. 2009. View Article : Google Scholar : PubMed/NCBI
14	Oldershaw RA, Baxter MA, Lowe ET, Bates N, Grady LM, Soncin F, Brison DR, Hardingham TE and Kimber SJ: Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol. 28:1187–1194. 2010. View Article : Google Scholar : PubMed/NCBI
15	Suchorska WM, Augustyniak E, Richter M and Trzeciak T: Comparison of four protocols to generate chondrocyte-like cells from human induced pluripotent stem cells (hiPSCs). Stem Cell Rev. 13:299–308. 2017. View Article : Google Scholar : PubMed/NCBI
16	Mahmoudifar N and Doran PM: Chondrogenesis and cartilage tissue engineering: The longer road to technology development. Trends Biotechnol. 30:166–176. 2012. View Article : Google Scholar : PubMed/NCBI
17	Moon SH, Ju J, Park SJ, Bae D, Chung HM and Lee SH: Optimizing human embryonic stem cells differentiation efficiency by screening size-tunable homogenous embryoid bodies. Biomaterials. 35:5987–5997. 2014. View Article : Google Scholar : PubMed/NCBI
18	Preda MB, Burlacu A and Simionescu M: Defined-size embryoid bodies formed in the presence of serum replacement increases the efficiency of the cardiac differentiation of mouse embryonic stem cells. Tissue Cell. 45:54–60. 2013. View Article : Google Scholar : PubMed/NCBI
19	Van Winkle AP, Gates ID and Kallos MS: Mass transfer limitations in embryoid bodies during human embryonic stem cell differentiation. Cells Tissues Organs. 196:34–47. 2012. View Article : Google Scholar : PubMed/NCBI
20	Hwang YS, Chung BG, Ortmann D, Hattori N, Moeller HC and Khademhosseini A: Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci USA. 106:16978–16983. 2009. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Suchorska WM, Lach MS, Richter M, Kaczmarczyk J and Trzeciak T: Bioimaging: An useful tool to monitor differentiation of human embryonic stem cells into chondrocytes. Ann Biomed Eng. 44:1845–1859. 2016. View Article : Google Scholar : PubMed/NCBI
23	Dias AD, Unser AM, Xie Y, Chrisey DB and Corr DT: Generating size-controlled embryoid bodies using laser direct-write. Biofabrication. 6:0250072014. View Article : Google Scholar : PubMed/NCBI
24	Xu F, Sridharan B, Wang S, Gurkan UA, Syverud B and Demirci U: Embryonic stem cell bioprinting for uniform and controlled size embryoid body formation. Biomicrofluidics. 5:222072011. View Article : Google Scholar : PubMed/NCBI
25	Pettinato G, Wen X and Zhang N: Formation of well-defined embryoid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays. Sci Rep. 4:74022014. View Article : Google Scholar : PubMed/NCBI
26	Ng ES, Davis RP, Azzola L, Stanley EG and Elefanty AG: Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood. 106:1601–1603. 2005. View Article : Google Scholar : PubMed/NCBI
27	Giobbe GG, Zagallo M, Riello M, Serena E, Masi G, Barzon L, Di Camillo B and Elvassore N: Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells. Biotechnol Bioeng. 109:3119–3132. 2012. View Article : Google Scholar : PubMed/NCBI
28	Messana JM, Hwang NS, Coburn J, Elisseeff JH and Zhang Z: Size of the embryoid body influences chondrogenesis of mouse embryonic stem cells. J Tissue Eng Regen Med. 2:499–506. 2008. View Article : Google Scholar : PubMed/NCBI
29	Cha JM, Bae H, Sadr N, Manoucheri S, Edalat F, Kim K, Kim SB, Kwon IK, Hwang YS and Khademhosseini A: Embryoid body size-mediated differential endodermal and mesodermal differentiation using polyethylene glycol (PEG) Microwell Array. Mac Res. 23:245–255. 2015. View Article : Google Scholar
30	Lee EJ, Lee HN, Kang HJ, Kim KH, Hur J, Cho HJ, Lee J, Chung HM, Cho J, Cho MY, et al: Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A. 16:705–715. 2010. View Article : Google Scholar : PubMed/NCBI
31	Cheng A, Kapacee Z, Peng J, Lu S, Lucas RJ, Hardingham TE and Kimber SJ: Cartilage repair using human embryonic stem cell-derived chondroprogenitors. Stem Cells Transl Med. 3:1287–1294. 2014. View Article : Google Scholar : PubMed/NCBI
32	Yang SL, Harnish E, Leeuw T, Dietz U, Batchelder E, Wright PS, Peppard J, August P, Volle-Challier C, Bono F, et al: Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis. Protein Cell. 3:934–942. 2012. View Article : Google Scholar : PubMed/NCBI
33	Goh SK, Olsen P and Banerjee I: Extracellular matrix aggregates from differentiating embryoid bodies as a scaffold to support ESC proliferation and differentiation. PLoS One. 8:e618562013. View Article : Google Scholar : PubMed/NCBI
34	Shukla S, Nair R, Rolle MW, Braun KR, Chan CK, Johnson PY, Wight TN and McDevitt TC: Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J Histochem Cytochem. 58:345–358. 2010. View Article : Google Scholar : PubMed/NCBI
35	Okamura N, Hasegawa M, Nakoshi Y, Iino T, Sudo A, Imanaka-Yoshida K, Yoshida T and Uchida A: Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage. 18:839–848. 2010. View Article : Google Scholar : PubMed/NCBI
36	Tavella S, Raffo P, Tacchetti C, Cancedda R and Castagnola P: N-CAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res. 215:354–362. 1994. View Article : Google Scholar : PubMed/NCBI